NOT-DA-24-050: Notice of NIDA Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"

Notice of NIDA Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)"

Notice Number:

NOT-DA-24-050

Key Dates

Release Date:

October 16, 2024

Related Announcements

October 2, 2024 - NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed). See NOFO PA-25-080

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform potential applicants that effective immediately the National Institute on Drug Abuse (NIDA) will participate in PA-25-080 “NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)” issued by the National Institutes of Health.

The following text (in italics) has been added to reflect NIDA's participation:

Part 1. Overview Information

Components of Participating Organizations

National Institute on Drug Abuse (NIDA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.279

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Yuki Lama, Ph.D
National Institute on Drug Abuse (NIDA)
Phone: 310-443-4577
Email: NIDAreferral@mail.nih.gov